Predictive Factors for the Benefit of Stereotactic Body Radiotherapy for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience
Sponsor study identifier
observational
25
1 country
1
Study Start
January 2010
Actual (reported)Primary Completion
July 2015
Actual (reported)Study Completion
July 2018
Actual (reported)Single-institution retrospective analysis for predictive factors of prostate cancer patients presenting with isolated or limited lymph node (LN) recurrence (1-3 lesions) on F-Ccholine PET-CT (CholPET) treated with SBRT between January 2010 and July 2015.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2010
Actual (reported)July 2015
Actual (reported)July 2018
Actual (reported)July 19, 2018
Actual (reported)July 27, 2018
Actual (reported)time to biochemical recurrence
time interval from SBRT until second PSA rise
18 months
biochemical response rate
18 months
time interval between SBRT and ADT start
18 months
Stereotactic Radiotherapy of lymphnode recurrence after prostatectomy +/- salvage radiotherapy
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
single-Institution cohort of male patients 18-85 years of age, with recurrent prostate cancer after radical prostatectomy in 1-3 lymphnodes, prospectively registered in a local institutional database
Juergen Curschmann
Zurich, 8032, Switzerland
Daniel R Zwahlen, MD
Kantonsspital Graubünden
25 participants (actual enrollment reported by the registry).
First Submitted
July 19, 2018
First Posted
July 27, 2018
Study Start
January 2010
Actual (reported)Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era
Contact the study team to confirm eligibility.
Primary Completion
July 2015
Actual (reported)Study Completion
July 2018
Actual (reported)Last Updated
August 17, 2018
Record last verified: 2018-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: